Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CPB1 | P15086 | 2/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25641905 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL3223998 | 1.00 | ALDH1A1 (0.55) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL393163 | 0.89 | CPB1 (0.57) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL25641902 | 0.89 | CPB1 (0.57) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL9875420 | 0.89 | CPB1 (0.57) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL8759021 | 0.89 | CPB1 (0.57) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL9875439 | 0.84 | ALDH1A1 (0.51) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL9877215 | 0.82 | ALDH1A1 (0.50) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL9875332 | 0.82 | ALDH1A1 (0.50) | ALDH1A1GAATSHRCPB1EPHX1 | |
| SCHEMBL9876032 | 0.81 | ALDH1A1 (0.48) | ALDH1A1GAATSHRCPB1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348363-A1 | COMPOUNDS AND THEIR USE | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2023-11-02 | — | — | US | disclosed |
| EP-2129224-A1 | 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS | Anadys Pharmaceuticals, Inc. (US) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008124450-A1 | 5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS | ANADYS PHARMACEUTICALS, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348363-A1 | COMPOUNDS AND THEIR USE | RXFP1, RXFP3, RXFP2 | ALDH1A1 1531/4885GAA 3044/4885TSHR 436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.